These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Lipid anomalies during renal insufficiency: consequences on the progression of renal insufficiency and cardiovascular risk]. Moulin B Nephrologie; 2000; 21(7):339-41. PubMed ID: 11200605 [No Abstract] [Full Text] [Related]
5. [Hypertension, atherosclerosis and kidney]. Zuccalà A; Fiorenza S; Rapanà R; Santoro A G Ital Nefrol; 2005; 22 Suppl 31():S9-14. PubMed ID: 15786409 [TBL] [Abstract][Full Text] [Related]
6. Statins and renal function. Elisaf M; Mikhailidis DP Angiology; 2002; 53(5):493-502. PubMed ID: 12365855 [TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperlipidemia in human renal disease. D'Amico GD; Gentile MG Miner Electrolyte Metab; 1993; 19(3):196-204. PubMed ID: 8232107 [TBL] [Abstract][Full Text] [Related]
8. Hyperlipidemia and its management in renal disease. Massy ZA; Kasiske BL Curr Opin Nephrol Hypertens; 1996 Mar; 5(2):141-6. PubMed ID: 8744535 [TBL] [Abstract][Full Text] [Related]
9. Second International Symposium on Lipids, Atherosclerosis and the Kidney: summary of scientific presentations. Klahr S; D'Amico G Nephrol Dial Transplant; 1994; 9(11):1660-3. PubMed ID: 7870362 [No Abstract] [Full Text] [Related]
10. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease]. Ravera M; Paoletti E Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148 [TBL] [Abstract][Full Text] [Related]